RMCFX
Price
$14.23
Change
+$0.05 (+0.35%)
Updated
Jul 31 closing price
Net Assets
389.89M
VSCIX
Price
$141.38
Change
-$0.34 (-0.24%)
Updated
Jul 31 closing price
Net Assets
188.57B
Interact to see
Advertisement

RMCFX vs VSCIX

RMCFX vs VSCIX Comparison Chart in %
View a ticker or compare two or three
VS
RMCFX vs. VSCIX commentary
Aug 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RMCFX is a Buy and VSCIX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VSCIX has more cash in the bank: 189B vs. RMCFX (390M). VSCIX pays higher dividends than RMCFX: VSCIX (1.23) vs RMCFX (0.00). RMCFX was incepted earlier than VSCIX: RMCFX (24 years) vs VSCIX (29 years). RMCFX (1.57) is less costly to investors than VSCIX (0.03). RMCFX is a more actively managed with annual turnover of: 38.00 vs. VSCIX (17.00). RMCFX has a lower initial minimum investment than VSCIX: RMCFX (2000) vs VSCIX (5000000). RMCFX annual gain was more profitable for investors over the last year : 31.03 vs. VSCIX (22.58). VSCIX return over 5 years is better than : 35.13 vs. RMCFX (-8.02).
RMCFXVSCIXRMCFX / VSCIX
Total Expense Ratio1.490.034,967%
Annual Report Gross Expense Ratio1.570.035,233%
Fund Existence24 years29 years-
Gain YTD33.74114.591231%
Front LoadN/AN/A-
Min. Initial Investment200050000000%
Min. Initial Investment IRAN/AN/A-
Net Assets390M189B0%
Annual Yield % from dividends0.001.23-
Returns for 1 year31.0322.58137%
Returns for 3 years28.7843.4466%
Returns for 5 years-8.0235.13-23%
Returns for 10 years26.80156.0717%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GSPKX20.050.12
+0.60%
Goldman Sachs US Eq Div and Prem Instl
GSIQX23.62N/A
N/A
Goldman Sachs GQG Ptnrs Intl Opps R
HSIIX29.59-0.08
-0.27%
Carillon Eagle Small Cap Growth I
CCWSX21.56-0.16
-0.74%
Baird Chautauqua International Gr Inv
RYCFX49.56-1.15
-2.27%
Rydex Biotechnology C